First Trust Advisors
AGN

First Trust Advisors’s Allergan Inc AGN Stock Holding History

First Trust Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-303,041
Closed -$64.4M – 2402
2014
Q4 		$64.4M Sell
303,041
-60,555
-17% -$12M 0.22% 96
2014
Q3 		$64.8M Buy
363,596
+107,099
+42% +$17.8M 0.25% 69
2014
Q2 		$43.4M Sell
256,497
-65,251
-20% -$10.2M 0.18% 112
2014
Q1 		$39.9M Buy
321,748
+232,628
+261% +$28.3M 0.18% 113
2013
Q4 		$9.9M Buy
89,120
+11,008
+14% +$1.05M 0.05% 624
2013
Q3 		$7.07M Sell
78,112
-93,382
-54% -$8.38M 0.04% 688
2013
Q2 		$14.4M Buy
+171,494
New +$17.8M 0.09% 300

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

First Trust Advisors's AGN Position: Q1 2015 in Review

First Trust Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 303,041 shares — an estimated $64.4M sold.

First Trust Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $64.8M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • First Trust Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • First Trust Advisors sold 303,041 Allergan Inc shares in Q1 2015, an estimated $64.4M.
  • First Trust Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • First Trust Advisors's Allergan Inc position peaked at $64.8M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on First Trust Advisors's 13F filing for Q1 2015, filed 4 May 2015.